Rankings
▼
Calendar
IART Q4 2024 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena
IART
Integra LifeSciences Holdings Corporation
$738M
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$443M
+11.5% YoY
Gross Profit
$249M
56.3% margin
Operating Income
$36M
8.0% margin
Net Income
$19M
4.4% margin
EPS (Diluted)
$0.25
QoQ Revenue Growth
+16.2%
Cash Flow
Operating Cash Flow
$51M
Free Cash Flow
$11M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$4.0B
Total Liabilities
$2.5B
Stockholders' Equity
$1.5B
Cash & Equivalents
$246M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$443M
$397M
+11.5%
Gross Profit
$249M
$226M
+10.0%
Operating Income
$36M
$36M
-1.2%
Net Income
$19M
$20M
-2.0%
Revenue Segments
Codman Specialty Surgical
$315M
71%
Tissue Technologies
$128M
29%
Geographic Segments
UNITED STATES
$336M
80%
Asia Pacific
$44M
10%
Europe
$42M
10%
← FY 2024
All Quarters
Q1 2025 →